Note: Ingredients listed on restricted chemical lists
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
<0.1
EC/CAS
220-239-6/2682-20-4
Name of the chemical
2-Methyl-2H-isothiazol-3-one
Concentration
<0.1 >=0.0015%
General Information
Version
SDS-00023 - Optitrol Malaria
Revision date
2026-01-15
Product name
Optitrol Malaria
1.2.1 Relevant identified uses
In Vitro Diagnostic Use
supplier name
LGC Clinical Diagnostics, Inc
Emergency telephone
1-800-424-9300, +1 703-527-3887
Icons in SDS
Company Information
company name
LGC Clinical Diagnostics, Inc
e-mail address of the competent person responsible for the Safety Data Sheet
CDx-CustomerService@LGCGroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Regulation (EC) No. 1272/2008 [CLP]] Classification of the substance or mixture Classification according to
Contains
2-Methyl-4-isothiazolin-3-one(MI)
Signal word
Warning
Hazard statements
H317 - May cause an allergic skin reaction.
Precautionary statements
P261 - Avoid breathing dust, fume, gas, mist, vapors and spray P280 - Wear protective gloves P321 - Specific treatment (see supplemental first aid instructions on this label) P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P362 + P364 - Take off contaminated clothing and wash it before reuse P501 - Dispose of contents and container in accordance with local, regional, national, and international regulations as applicable
2.3 Other hazards
No information available.
PBT Substances
& vPvB This mixture contains no substance considered to be persistent, bioaccumulating or toxic This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB). Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Chemical name
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Skin sensitisation Category 1 - (H317)
